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Abstract
Purpose
To investigate whether adverse experiences in childhood predict non-adherence to statin
therapy in adulthood.
Methods
A cohort of 1378 women and 538 men who initiated statin therapy during 2008–2010 after
responding to a survey on childhood adversities, was followed for non-adherence during
the first treatment year. Log-binomial regression was used to estimate predictors of non-ad-
herence, defined as the proportion of days covered by dispensed statin tablets <80%. In
fully adjusted models including age, education, marital status, current smoking, heavy alco-
hol use, physical inactivity, obesity, presence of depression and cardiovascular comorbidi-
ty, the number of women ranged from 1172 to 1299 and that of men from 473 to 516,
because of missing data on specific adversities and covariates.
Results
Two in three respondents reported at least one of the following six adversities in the family:
divorce/separation of the parents, long-term financial difficulties, severe conflicts, frequent
fear, severe illness, or alcohol problem of a family member. 51% of women and 44% of men
were non-adherent. In men, the number of childhood adversities predicted an increased
risk of non-adherence (risk ratio [RR] per adversity 1.11, 95% confidence interval [CI] 1.01–
1.21], P for linear trend 0.013). Compared with those reporting no adversities, men reporting
3–6 adversities had a 1.44-fold risk of non-adherence (95% CI 1.12–1.85). Experiencing se-
vere conflicts in the family (RR 1.27, 95% CI 1.03–1.57]) and frequent fear of a family mem-
ber (RR 1.27, 95% CI 1.00–1.62]) in particular, predicted an increased risk of non-
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adherence. In women, neither the number of adversities nor any specific type of adversity
predicted non-adherence.
Conclusions
Exposure to childhood adversity may predict non-adherence to preventive cardiovascular
medication in men. Usefulness of information on childhood adversities in identification of
adults at high risk of non-adherence deserves further research.
Introduction
According to a recent meta-analysis [1], ~9% of cardiovascular events can be attributable to
non-adherence to preventive cardiovascular medications. The estimated prevalence of non-ad-
herence to statins, defined as taking<80% of the prescribed medication, was 46%, translating
to 9 excess deaths due to cardiovascular disease per 100,000 Europeans offered statin therapy
per year [1]. Multiple patient, physician, and health system-related factors as well as their inter-
actions influence adherence to long-term medication [2, 3]. Suggested patient-related factors
leading to non-adherence include presence of psychological problems, cognitive impairment,
beliefs about the treatment and illness, and high cost of medication [2].
To date, several studies have shown that early-life socioeconomic adversities predict cardio-
vascular disease in adults [4, 5]. Furthermore, childhood adversity has been associated with the
emergence of cardiovascular risk factors, such as high systolic blood pressure [6], obesity [7],
type 2 diabetes [7], binge drinking [8], and smoking [9, 10], and higher overall cardiometabolic
risk in adulthood [11]. Longitudinal studies suggest an increased risk of cardiovascular events
among individuals reporting such childhood adversities as financial difficulties, interpersonal
conflicts, long-term illness in the family [12], or physical abuse [13]. Moreover, childhood ad-
versities are strongly linked with adulthood depression [14], another cardiovascular risk factor
and a correlate of non-adherence [15, 16]. Accordingly, it seems plausible that the associations
between childhood adversity and cardiovascular disease later in life may be partly mediated by
medication non-adherence. To our knowledge, one previous study, including men only, has in-
vestigated the association between childhood adversity and non-adherence to cardiovascular
medication in adulthood: low socioeconomic position in childhood, operationalized as father’s
occupation at birth, was found to predict discontinuation of statin therapy in middle age [17].
In this study, we determined whether the number or type of childhood adversities predict
non-adherence to statin therapy among new statin users in the Finnish Public Sector study co-
hort [18]. As there are sex-differences in cardiovascular disease rates [19] and adherence to car-
diovascular medication [20], and the reasons for non-adherence may vary by sex [16, 21, 22],
we stratified our analyses by sex.
Materials and Methods
Study population and design
The study’s register cohort includes all the employees of 10 towns and 6 hospital districts who
had a6-month job contract in 1991–2005. Nested survey cohorts, then, include all employees
at the time of the surveys repeated by 4-year intervals since 2000. In 2008/2009, the self-admin-
istered questionnaire inquired information on childhood adversities; consequently, we first in-
cluded those participants who were employed by the ten towns and responded to the survey in
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2008/2009 (42,877 responded; response rate 69%). Using the unique personal identification
numbers, we linked statin dispensation data [23] to the survey data and restricted the sample
to those who initiated statin therapy after the survey. An initiator refers to an individual with
no statin dispensations within one year preceding the survey. The final study sample included
1916 initiators with full data on statin purchases for a 12-month follow-up by December 31,
2011 (Fig 1).
Assessment of childhood adversities
We assessed the occurrence of childhood adversities using six survey questions modified from
Statistics Finland’s Survey of living conditions [24]. Respondents were asked whether they had
experienced the following adversities: parents’ divorce/separation, long-term financial difficul-
ties in the family, severe conflicts in the family, frequent fear of a family member, severe or
chronic illness of a family member, and alcohol problem of a family member (response catego-
ries: no, yes, or cannot say). The items were analysed separately and as a summary variable (0,
1, 2, or 3–6 adversities). The category “cannot say” was coded as missing information when the
items were analyzed separately. For the summary variable those with either type of missing in-
formation on an item were coded as not having that specific adversity. The reliability of this
summary measure has been previously reported to be good (κ-values of responses with a
5-year interval from 0.56 to 0.90 [25]), and the measures has been shown to longitudinally pre-
dict, for instance, coronary heart disease [12] and depression [14].
Fig 1. Chart of the sample selection.
doi:10.1371/journal.pone.0127638.g001
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Assessment of adherence
The Finnish Prescription Register [23] is a pharmacy-claims database, managed by the Social
Insurance Institution, provided data on statin use. The register contains records of all prescrip-
tion drug purchases reimbursed to residents in non-institutional settings. For each drug, the
dispensing date, the World Health Organization Anatomical Therapeutic Chemical (ATC)
classification code [26], and the quantity dispensed are recorded. As the register contains infor-
mation only on prescriptions that are both dispensed and reimbursed, we were not able to
study primary non-adherence to statin therapy.
The outcome was non-adherence to statins (ATC code C10AA) during the 365 days after
the initiation in 2008–2010. We measured adherence as the proportion of days covered by the
dispensed tablets [27], on the assumption of a daily dose of 1 tablet [28]. We defined non-ad-
herence as proportion of days covered<80% [1].
Finland has a universal drug reimbursement system [29]. All patients are entitled to a basic
reimbursement which covered 42% of the price of statins during the study years. Patients with
dyslipidaemia associated with coronary artery disease or familial hypercholesterolemia are an
exception and, for them, 72% of the price of statins was reimbursed. Statin therapies were typi-
cally initiated with low-cost generic simvastatin (97% in 2008 [30]); thus, the impact of statin
costs on non-adherence is likely to be small in our study.
Covariates
We included sex, age, education, and marital status as sociodemographic covariates. Level of
education, obtained from Statistics Finland, was classified as high (university or college degree)
or low (vocational or basic education) [31]. Information on marital status (married or cohabit-
ing vs. single, divorced, or widowed) and lifestyle-related risks came from the survey responses.
Current smoking was defined as smoking (almost) daily. Heavy alcohol use was defined as con-
suming>210 grams of pure alcohol/week [32] based on the habitual frequency and amount of
beer, wine, and spirits intake transformed into grams of pure alcohol. In addition, those re-
spondents who reported that they had passed out due to heavy drinking during the past 12
months were classified as heavy alcohol users. Physical activity was measured by the Metabolic
Equivalent Task index; the sum score of Metabolic Equivalent Task hours/day<2 indicated
physical inactivity. Self-reported weight and height were used to determine body mass index
and obesity (body mass index30 kg/m2). A binary variable (any of the five risk factors vs.
none) was created to indicate the presence of lifestyle-related risk.
Health indicators potentially affecting adherence [3] were extracted from the registers of the
Social Insurance Institution and the Finnish Care Register [23]. Cardiovascular comorbidity
was defined as entitlement to higher reimbursement for medication of chronic hypertension,
heart failure, coronary heart disease, or diabetes at statin initiation, or as any hospitalization re-
lated to these conditions, stroke, or arrhythmia within 36 months prior to statin initiation. De-
pression was defined as hospitalization for depression or use of antidepressants (ATC code
N06A) during 36 months before statin initiation.
Statistical analyses
We stratified all analyses by sex. Statistical significance of the difference in the age distributions
between sexes was tested with the Student’s t test and those in categorical variables with the
Chi square test. We estimated the risk ratios (RR) for non-adherence and their 95% confidence
intervals (CI) with log-binomial regression models. As the effect of childhood adversities on
non-adherence may be partly mediated through adulthood socioeconomic status, comorbidi-
ties, lifestyle-related risks, and depression and the analyses adjusted for (or stratified by) these
Childhood Adversity and Medication Non-Adherence
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variables may be over-adjusted [33], the model was first adjusted for age at statin initiation
only (Model 1) and then further for education and marital status (Model 2). Finally, the fully
adjusted model (Model 3) included current smoking, heavy alcohol use, physical inactivity,
obesity, depression and cardiovascular comorbidity in addition to the preceding variables
(Model 3). Age was entered into the models as a continuous variable and all other covariates as
categorical variables (dichotomized as described in the preceding section).
We first estimated the association between the four-class adversity measure (0, 1, 2, or 3–6
adversities) and non-adherence. The linear trend in this association was tested treating the
number of adversities as a continuous variable. Second, we examined each type of adversity
separately. The numbers of participants included in these analyses vary as those participants
missing data on the adversity in question or covariates were excluded from the type specific
analyses. Sex-differences were tested using the interaction term “sexadversity”. To examine
variations in the associations between the number of adversities and non-adherence across the
subpopulations defined by age, education, marital status, presence of lifestyle-related risk, and
comorbidity, we included the interaction term “subpopulation characteristicnumber of adver-
sities” in the age-adjusted models.
Two-sided P values<0.05 were interpreted as statistically significant. Statistical analyses
were conducted with SAS 9.2 statistical software (SAS Institute, Inc., Cary, NC, USA).
Ethics statement
According to the Finnish law, written consent is not required for register-based and survey re-
search, as long as participation is voluntary. The participants of the Finnish public Sector study
were informed about the aims of the study and the possible record linkages. Participants’ infor-
mation was anonymized and de-identified prior to analysis. The Ethics Committee of the Hel-
sinki and Uusimaa Hospital District approved the study.
Results
We identified 1378 (72%) female and 538 (28%) male respondents who initiated statin therapy
after the survey by December 31, 2010 (Table 1, S1 File). Among these initiators, 71% of
women and 63% of men were free of cardiovascular comorbidities (P = 0.002). Compared to
women, men were younger, more commonly married or cohabiting, current smokers and
heavy alcohol users (P<0.001). Conversely, depression was twice as prevalent among women
as among men (21% versus 10%, P<0.001).
Two in three respondents reported one or more childhood adversities (Table 1). Severe ill-
ness of a family member was the most common adversity, 37% of women and 32% of men re-
porting it. The largest relative difference between the sexes appeared in reporting fear of a
family member (19% in women and 14% in men, P = 0.012).
Overall, 237 (44%) of men and 700 (51%) of women were deemed non-adherent to statins
during the first treatment year (P = 0.008). We found no association between the number of
childhood adversities and the risk of non-adherence in women (Table 2). In men, however, the
risk of non-adherence increased with the number of adversities (P for trend 0.013, P for inter-
action with sex 0.048). Specifically, those men with 3–6 adversities had a 1.44-fold risk of non-
adherence (95% CI 1.12–1.85) compared with men reporting no adversities in the fully adjust-
ed analyses (Table 2). As shown in Fig 2 (Table B in S1 File), the risk of non-adherence tended
to increase with the number of adversities in all subpopulations of men with one exception.
Among men with cardiovascular comorbidities, the risk of non-adherence remained low in
men with 1–2 adversities; however, among men with 3–6 adversities, the risk of non-adherence
almost doubled in comparison with those with no adversities (age-adjusted RR, 1.93, 95% CI
Childhood Adversity and Medication Non-Adherence
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Table 1. Baseline characteristics by sex.
Characteristic Women (n = 1378) Men (n = 538) P valuea
Age (year)b 56.8 ± 7.0 (29–75) 55.0 ± 8.0 (31–74) <.0001
Education 0.86
Low 749 (54) 290 (54)
High 629 (46) 248 (46)
Married or cohabiting <.0001
No 398 (29) 97 (18)
Yes 970 (71) 435 (82)
Current smoking <.0001
No 1186 (87) 423 (79)
Yes 183 (13) 111 (21)
Heavy alcohol usec <.0001
No 1248 (91) 369 (69)
Yes 124 (9) 167 (31)
Physical inactivity 1.00
No 858 (63) 336 (63)
Yes 511 (37) 200 (37)
Obesity 0.07
No 963 (73) 404 (77)
Yes 364 (27) 123 (23)
Depressiond <.0001
No 1091 (79) 486 (90)
Yes 287 (21) 52 (10)
Cardiovascular comorbiditye 0.002
No 972 (71) 340 (63)
Yes 406 (29) 198 (37)
Childhood adversities in the family
Parents’ divorce 191 (14) 86 (16) 0.18
Financial difﬁculties 374 (30) 147 (30) 0.85
Severe conﬂicts 339 (27) 130 (26) 0.72
Fear of family member 255 (19) 74 (14) 0.012
Severe illness 494 (37) 167 (32) 0.07
Alcohol problem 339 (25) 127 (25) 0.77
Number of childhood adversities 0.66
0 494 (36) 204 (38)
1 366 (27) 136 (25)
2 203 (15) 85 (16)
3–6 315 (23) 113 (21)
Data are expressed as mean ± standard deviation (range) or number and proportion, n (%). The n do not sum up to 1378 for women and 538 for men for
some variables because of missing data.
aStatistical signiﬁcance of differences between women and men tested using the t-test for age and the Chi square test for categorical variables.
b Age distributions presented also in Table A in S1 File.
c >210 grams of pure alcohol/week and/or 1 extreme drinking occasions/past year
dHospitalization for depression or use of antidepressants.
eDiabetes mellitus, hypertension, coronary insufﬁciency, coronary heart disease, cardiac arrhythmia, and/or cerebrovascular disease.
doi:10.1371/journal.pone.0127638.t001
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1.28–2.93). In contrast, among men without comorbidities, the corresponding age-adjusted RR
was 1.18 (95% CI 0.88–1.58) (P for interaction 0.07).
Among women, none of the individual childhood adversities predicted the risk of non-ad-
herence (Table 3). Among men, experiencing severe conflicts in the family and fear of a family
member were associated with a significantly increased risk of non-adherence (fully adjusted
RRs 1.27, P< 0.05, Table 3). The four other adversities were not significantly associated with
the risk of non-adherence among men. Overall, adjustments for different sets of potential con-
founders and mediators had little impact on the observed associations (Tables 2 and 3).
Discussion
In this analysis of almost 2000 statin initiators in Finland, childhood adversity predicted non-
adherence to statin therapy in men during the first treatment year. One in five men reported
three or more childhood adversities and had a ~40% increased risk of non-adherence com-
pared with men with no childhood adversities. Experience of conflicts in the family and fear of
a family member, in particular, were associated with an increased risk of non-adherence.
Women reported childhood adversities as frequently as did men; however, no associations
were evident between the number of childhood adversities nor any specific adversity and non-
adherence in women.
Table 2. Risk ratios of non-adherence by the number of childhood adversities among statin initiators.
Number of adversities Model 1 Model 2 Model 3
RR (95% CI) RR (95% CI) RR (95% CI)
Women (n = 1299)
0 1.00 1.00 1.00
1 0.99 (0.87–1.13) 0.99 (0.86–1.13) 1.02 (0.89–1.17)
2 0.93 (0.79–1.11) 0.94 (0.79–1.11) 0.95 (0.80–1.13)
3–6 1.05 (0.91–1.20) 1.05 (0.91–1.20) 1.05 (0.91–1.21)
linear trend 1.01 (0.96–1.06) 1.01 (0.96–1.05) 1.00 (0.96–1.05)
P = 0.70 P = 0.71 P = 0.62
Men (n = 516)
0 1.00 1.00 1.00
1 1.07 (0.82–1.39) 1.10 (0.85–1.43) 1.07 (0.82–1.40)
2 1.06 (0.79–1.44) 1.06 (0.79–1.44) 1.11 (0.81–1.50)
3–6 1.40 (1.10–1.78) 1.41 (1.11–1.79) 1.44 (1.12–1.85)
linear trend 1.11 (1.03–1.21) 1.11 (1.03–1.21) 1.11 (1.01–1.21)
P = 0.010 P = 0.010 P = 0.013
Note: RR = risk ratio; CI = conﬁdence interval
Non-adherence refers to proportion of days covered by statin therapy <80%.
Model 1: adjusted for age.
Model 2: adjusted for age, education, and marital status.
Model 3: adjusted for age, education, marital status, current smoking, heavy alcohol use, physical inactivity, obesity, depression, and
cardiovascular comorbidity.
Contrasts derived from log-binomial regression analyses including the interaction term sex*the number of adversities. P-values for the interaction term
0.040 (Model 1), 0.038 (Model 2) and 0.048 (Model 3).
Age was entered into the models as a continuous variable and other covariates as dichotomous variables (see Table 1 for categories). Participants
missing data on any covariate were excluded from the analyses.
doi:10.1371/journal.pone.0127638.t002
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Our findings support previous observations on the high rates of non-adherence to statin
therapy [1, 20] as well as on the sex-differences in the patterns of and reasons for non-adherence
[16, 20, 21, 22, 34, 35]. In a cross-sectional survey of prescription drug users in Sweden, for ex-
ample, men reported more commonly forgetting and changing the dosages than did women
[22]. Women, conversely, reported more commonly that they filled prescriptions but did not
take the medication. In a US survey [34], ~70% of lipid-lowering medication users reported
some form of unintentional non-adherence during the previous six months, men reporting for-
getfulness more commonly than women. Also the role of psychopathology in non-adherence
may differ between men and women. One study found that the presence of anxiety or depres-
sion increased the likelihood of non-adherence to antihypertensive medication among older
men but not among women [35]. We recently reported 9-year trajectories of adherence to anti-
hypertensive medication before and after the onset of depression [16]. After the depression
onset, men had a 1.5 times higher rate of “days-not-treated” compared to the years before de-
pression while no difference was observed among women. In another study, we observed a
Fig 2. Risk of non-adherence (95% confidence interval) by the number of childhood adversities in subpopulations of men.
doi:10.1371/journal.pone.0127638.g002
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1.3-fold increase in the prevalence of poor adherence (proportion days covered<40%) to anti-
hypertensive medication after retirement among men and women with hypertension; however,
among patients with diabetes, the prevalence of poor adherence to antidiabetic medication in-
creased only in men [21].
Although literature on the consequences of childhood adversities is abundant, few studies
have investigated differences in the impact of childhood adversities on health outcomes and be-
haviours between sexes; the findings have been mixed with some [12, 14, 36, 37] but not all [6,
9, 10] showing sex-differences. Overall, women seem more susceptible to the effect of child-
hood adversities on cardiovascular disease [12], depression [14] multiple health problems [36]
and premature death [37]; sex-differences in the associations between adversities and health
behaviours have been less consistent [9, 10]. As pointed out by Fuller-Thompson et al. [10],
further research is needed to clarify how childhood adversities influence health outcomes and
health behaviours differentially by sex.
One potential explanation for the increased risk of non-adherence among those exposed to
childhood adversities is that adherence to preventive medication, such as statin therapy, is an
aspect of future orientation. In behavioural economics, the characteristic of undervaluing fu-
ture benefit is referred to as present-focused preferences or myopia [38]. Present-focused ori-
entation may emerge early in life because of adverse experiences; a child learns to focus on the
present because the future is uncertain. Such orientation may persist into adulthood; myopia
arises and leads to non-adherence because the patient is distracted by having to deal with more
Table 3. Risk ratios of non-adherence by the type of childhood adversity among statin initiators.
Type of adversity in the family Model 1 Model 2 Model 3
RR (95% CI) RR (95% CI) RR (95% CI)
Women
Parents’ divorce (n = 1291) 0.98 (0.85–1.15) 0.98 (0.85–1.14) 0.99 (0.85–1.15)
Financial difﬁculties (n = 1172) 1.04 (0.92–1.18) 1.04 (0.93–1.18) 1.05 (0.92–1.18)
Severe conﬂicts (n = 1194) 1.10 (0.98–1.24) 1.10 (0.98–1.24) 1.10 (0.97–1.24)
Fear of family member (n = 1253) 1.07 (0.93–1.21) 1.07 (0.93–1.21) 1.06 (0.93–1.22)
Severe illness (n = 1269) 0.98 (0.88–1.10) 0.98 (0.88–1.10) 1.00 (0.90–1.12)
Alcohol problem (n = 1261) 1.06 (0.94–1.19) 1.06 (0.94–1.19) 1.05 (0.93–1.19)
Men
Parents’ divorce (n = 505) 1.20 (0.94–1.51) 1.19 (0.94–1.51) 1.18 (0.93–1.49)
Financial difﬁculties (n = 473) 1.12 (0.91–1.38) 1.12 (0.91–1.38) 1.12 (0.91–1.39)
Severe conﬂicts (n = 480) 1.29 (1.05–1.59) 1.29 (1.05–1.58) 1.27 (1.03–1.57)
Fear of family member (n = 498) 1.30 (1.02–1.64) 1.30 (1.02–1.64) 1.27 (1.00–1.62)
Severe illness (n = 497) 1.17 (0.96–1.43) 1.17 (0.96–1.44) 1.17 (0.95–1.43)
Alcohol problem (n = 492) 1.15 (0.93–1.43) 1.15 (0.93–1.43) 1.15 (0.93–1.43)
Note: RR = risk ratio; CI = conﬁdence interval
Non-adherence refers to proportion of days covered by statin therapy <80%.
Comparisons between those with a speciﬁc adversity versus no such adversity.
Model 1: adjusted for age.
Model 2: adjusted for age, education and marital status.
Model 3: adjusted for age, education, marital status, current smoking, heavy alcohol use, physical inactivity, obesity, depression, and
cardiovascular comorbidity.
Age was entered into the models as a continuous variable and other covariates as dichotomous variables (see Table 1 for categories). Participants
missing data on a speciﬁc type of adversity or any of the covariates were excluded from the analyses.
doi:10.1371/journal.pone.0127638.t003
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urgent needs, such as financial worries or balancing work-family responsibilities. Second, as in-
tentional non-adherence may be regarded as risky behaviour [22], our observations are plausi-
ble in the light of the previous findings on the association between childhood adversity and
engagement in risky behaviours, such as excessive alcohol consumption and promiscuity, in
adulthood [39]. Third, unintentional non-adherence may result from impaired cognitive ca-
pacity [40], which has also been linked to early-life adversities [39]. Yet another possible route
linking childhood adversity and non-adherence is attachment [41]. In patients with diabetes,
dismissing attachment style has been associated with non-adherence to antidiabetic medica-
tions [42] and attachment styles characterized by low levels of collaboration have been associat-
ed with more missed primary care appointments compared to secure attachment style [43].
Finally, experiences of childhood maltreatment have been linked to high use of prescription
medications [44] and emergency room services [36, 45]. None of these potential mechanisms,
however, can explain why childhood adversities seem to have no association with non-adher-
ence to statin therapy among women.
Strengths and limitations
One previous study, including only men, has reported on the associations between childhood
adversity and adherence to cardiovascular medication in adults [17]; we were able to expand
the current knowledge to the associations in women and to those between a range of self-re-
ported adversities and adherence. We used refill data in a closed pharmacy system to measure
adherence instead of self-reported measures affected by recall and social desirability bias.
Nevertheless, we may have underestimated non-adherence if dispensed medications were
not used, and we could not differentiate between intentional and unintentional non-adherence.
We could not validate self-reporting of childhood adversities against any objective measures;
however, previous research suggests that adversities are more likely to be under-reported than
over-reported [46]. Furthermore we did not have information on severity of the adversities re-
ported by the respondents nor on their experiences of more severe adversities such as neglect,
physical or sexual abuse. Due to reliance on data from healthcare utilization databases, we may
have underascertained comorbidities, and therefore our fully adjusted models may be con-
founded by untreated depression and cardiovascular diseases. Childhood adversities and non-
adherence to cardiovascular medications are both known to affect survival [1, 37]; the associa-
tions observed among those who survived until the survey in 2008/09 and then initiated statin
use may have partly resulted from the selection process. The most likely direction of the above
biases is to attenuate the associations between childhood adversities and non-adherence. Due
to the small sample size we cannot rule out meaningful associations among women. For exam-
ple, the upper limit of the 95% CI of the RR for exposure to 3–6 adversities was 1.21. With the
risk of non-adherence being ~50% among women, this RR would translate to ~10 percent unit
increase in the risk of non-adherence. Our study population was a relatively homogenous sam-
ple of Finnish public-sector employees; the results could be different in other populations with
different social and economic barriers to adherence.
Most importantly, we did not assess whether childhood adversity was associated with non-
adherence over and above current adversity in the participants’ lives. Three types of causal
models are postulated in life-course epidemiology: the latency model, the pathways model, and
the accumulation model [47]. According to the latency model, early childhood adversity is hy-
pothesized to directly affect the outcome (here, medication non-adherence in adulthood) re-
gardless of adversities during later life (i.e., even if adverse circumstances stop). The reason is
that present-focused preferences become entrenched in childhood and persist into adult life
even if the adversity stops. According to the pathways model, early childhood adversity
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“begets” adult adversity; for example, family instability during childhood damages the child’s
emotional development so that he is unable to form lifelong attachments later in life. In this in-
stance, there is no direct effect of childhood adversity on the outcome; instead, it is completely
mediated by adversity in adulthood. Finally, the accumulation model posits that both child-
hood and adult adversity affect the outcome, so that the effects are additive. Unfortunately, our
study was not able to tease apart these alternative models.
Conclusions
We found exposure to childhood adversities to predict an increased risk of non-adherence to
statin therapy in men but not in women. Our findings imply that the effect of childhood adver-
sities on cardiovascular disease in adulthood may be partly mediated by medication non-ad-
herence. Further research is needed to confirm these findings in other populations, using
different adversity measures and regarding adherence to other preventive medications and use
of health services. In addition, further research is needed to determine the mechanisms under-
lying the association between childhood adversity and non-adherence in adults. Because child-
hood adversity may be a confounder in the association between non-adherence to
cardiovascular medication and cardiovascular events and mortality [1], controlling for it could
help reduce a “healthy adherer” bias [48] in future studies. Finally, since the available interven-
tions on adherence are expensive and should be directed to patients at highest risk of non-ad-
herence, information on childhood adversities could be useful in the development of a non-
adherence risk score for identification of those patients.
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